Doctor profile · Federal record
Dr. Matthew Rossi, APRN
Nurse Practitioner · New Smyrna, FL
- NPI 1104515170
- Accepts Medicare
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1055 N Dixie Fwy Ste 1
New Smyrna, FL 321686200
(386) 423-0505
fax (386) 423-0515
Credentials & registration
- NPI registered
- May 2023 — 3 yrs on file
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Florida #APRN9369727
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104515170. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$1,098
Transactions
52
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 13 | $246.70 | |
| Amgen INC. | 10 | $188.76 | |
| Grifols USA, LLC | 4 | $86.88 | |
| Abbvie INC. | 5 | $85.45 | |
| Genzyme Corporation | 3 | $66.55 | |
| Regeneron Healthcare Solutions, INC. | 2 | $59.73 | |
| Mylan Specialty L.P. | 3 | $54.04 | |
| Jazz Pharmaceuticals INC. | 2 | $48.72 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $45.56 | |
| Merck Sharp & Dohme LLC | 2 | $38.76 | |
| Pfizer INC. | 2 | $33.86 | |
| Microtransponder, INC. | 1 | $22.66 | |
| Optinose US, INC. | 1 | $22.36 | |
| Vanda Pharmaceuticals INC. | 1 | $20.46 | |
| Csl Behring | 1 | $20.00 |
By nature of payment
Frequently asked questions
What is Dr. Matthew Rossi's medical specialty?
Dr. Matthew Rossi practices Nurse Practitioner in New Smyrna, FL.
Where does Dr. Matthew Rossi practice?
Dr. Matthew Rossi practices at 1055 N Dixie Fwy Ste 1, New Smyrna, FL 321686200. Office phone: 3864230505.
What is Dr. Matthew Rossi's NPI?
Dr. Matthew Rossi's National Provider Identifier (NPI) is 1104515170, issued by NPPES.
Does Dr. Matthew Rossi accept Medicare assignment?
Yes. Dr. Matthew Rossi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.